$APHA $TLRY $TCNNF $MSOS $GTBIF The Tilray numbers would be considered awful for an American MSO, but for a Canadian stock it's considered good. The company’s recreational pot sales grew 49% year-over-year to $25.3 million. International medical sales jumped 191% to $11.7 million, while medical sales in Canada were up 26% to $4.2 million. Total cannabis revenue, which does not include $15.3 million in the hemp category, hit $41.2 million. Numbers for all of Canada and Europe. Less than $60 Million. Aphria should call off the merger and just go it alone